Last updated: March 2026
Ultra-short peptides that skip surface receptors and talk directly to DNA. Here's the complete breakdown of all 11 bioregulators, how to stack them, and why they work differently from everything else.
Most peptides bind surface receptors. Khavinson bioregulators do something fundamentally different — and that's why they've attracted 40+ years of research.
Each bioregulator targets a specific organ system. This is organ-specific medicine at the peptide level — one compound, one target.
Khavinson's research program used multiple bioregulators simultaneously. Here are the most studied and rationally designed combinations. Note: No human RCT data exists for most of these stacks specifically.
Unlike traditional peptides with daily continuous use, bioregulators are typically cycled — matching how Khavinson's research program was structured.
Most peptides are destroyed by stomach acid and gut enzymes. Bioregulators survive — and this is why.
Traditional peptides (15–40+ amino acids) are large enough that proteases cleave them into individual amino acids before absorption. The biological signal is destroyed in transit.
Khavinson bioregulators are ultra-short (2–4 amino acids) — small enough to be transported intact across the intestinal epithelium by dedicated peptide transporters (PEPT1 and PEPT2). These transporters evolved to absorb short nutritional peptides — bioregulators exploit the same system.
This is why oral doses are higher than injectable doses (lower bioavailability is compensated with higher dose) but the oral route is still effective. The 72-patient TBI trial used oral Pinealon — demonstrating clinically meaningful effects via this route.
Essential supplies for peptide research. For injectable protocols, these are the basics.
Affiliate links help support MeetPeptide at no extra cost to you.
Self-Assessment
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
This page is for educational and informational purposes only. It is not medical advice, and nothing here should be interpreted as a recommendation to use any bioregulator peptide. None of the Khavinson bioregulators cataloged on this page are approved by the FDA or EMA for human use. They are research compounds. Russian clinical data, while extensive (15M patients, 40+ years, 6 approved Russian pharmaceuticals), has not been submitted for Western regulatory review under current RCT standards. Dosing information is derived from published research — not medical prescription. Always consult a qualified healthcare provider before making any health decisions. MeetPeptide does not sell peptides or endorse their use outside of legitimate research settings.